Ozan Pamir - Net Worth and Insider Trading
Ozan Pamir Net Worth
The estimated net worth of Ozan Pamir is at least $16,363 dollars as of 2024-12-24. Ozan Pamir is the CFO of ChromaDex Corp and owns about 2,907 shares of ChromaDex Corp (CDXC) stock worth over $15,756. Ozan Pamir is also the Interim CFO of 180 Life Sciences Corp and owns about 201 shares of 180 Life Sciences Corp (ATNF) stock worth over $607. Details can be seen in Ozan Pamir's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ozan Pamir has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ozan Pamir
Ozan Pamir Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ozan Pamir owns 1 companies in total, including 180 Life Sciences Corp (ATNF) .
Click here to see the complete history of Ozan Pamir’s form 4 insider trades.
Insider Ownership Summary of Ozan Pamir
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATNF | 180 Life Sciences Corp | 2021-12-10 | Interim CFO |
Ozan Pamir Latest Holdings Summary
Ozan Pamir currently owns a total of 2 stocks. Among these stocks, Ozan Pamir owns 2,907 shares of ChromaDex Corp (CDXC) as of November 22, 2024, with a value of $15,756 and a weighting of 96.29%. Ozan Pamir also owns 201 shares of 180 Life Sciences Corp (ATNF) as of December 10, 2021, with a value of $607 and a weighting of 3.71%.
Latest Holdings of Ozan Pamir
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CDXC | ChromaDex Corp | 2024-11-22 | 2,907 | 5.42 | 15,756 |
ATNF | 180 Life Sciences Corp | 2021-12-10 | 201 | 3.02 | 607 |
Holding Weightings of Ozan Pamir
Ozan Pamir Form 4 Trading Tracker
According to the SEC Form 4 filings, Ozan Pamir has made a total of 1 transactions in ChromaDex Corp (CDXC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ChromaDex Corp is the acquisition of 2,907 shares on November 22, 2024, which cost Ozan Pamir around $21,397.
According to the SEC Form 4 filings, Ozan Pamir has made a total of 1 transactions in 180 Life Sciences Corp (ATNF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in 180 Life Sciences Corp is the acquisition of 10 shares on December 10, 2021, which cost Ozan Pamir around $14,706.
Insider Trading History of Ozan Pamir
- 1
Ozan Pamir Trading Performance
GuruFocus tracks the stock performance after each of Ozan Pamir's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ozan Pamir is -25.8%. GuruFocus also compares Ozan Pamir's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ozan Pamir within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ozan Pamir's insider trading performs compared to the benchmark.
Performance of Ozan Pamir
Ozan Pamir Ownership Network
Ozan Pamir Owned Company Details
What does 180 Life Sciences Corp do?
Who are the key executives at 180 Life Sciences Corp?
Ozan Pamir is the Interim CFO of 180 Life Sciences Corp. Other key executives at 180 Life Sciences Corp include director & Chief Executive Officer James N. Woody , COO / Chief Business Officer Quan Anh Vu , and director & 10 percent owner & Chief Executive Officer Marlene Krauss .
180 Life Sciences Corp (ATNF) Insider Trades Summary
Over the past 18 months, Ozan Pamir made no insider transaction in 180 Life Sciences Corp (ATNF). Other recent insider transactions involving 180 Life Sciences Corp (ATNF) include a net purchase of 25,000 shares made by James N. Woody , and a net sale of 25,000 shares made by Marc Feldmann .
In summary, during the past 3 months, insiders sold 0 shares of 180 Life Sciences Corp (ATNF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,316 shares of 180 Life Sciences Corp (ATNF) were sold and 1,316 shares were bought by its insiders, resulting in a net sale of 0 shares.
180 Life Sciences Corp (ATNF)'s detailed insider trading history can be found in Insider Trading Tracker table.
180 Life Sciences Corp Insider Transactions
Ozan Pamir Mailing Address
Above is the net worth, insider trading, and ownership report for Ozan Pamir. You might contact Ozan Pamir via mailing address: 2443 Fillmore St #380-17649, San Francisco Ca 94115.